Anti-LYZL6/ HEL-S-6a/ LYC1 functional antibody

Anti-LYZL6/ HEL-S-6a/ LYC1 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to LYZL6/LYZL6 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1088-Ab-1/ GM-Tg-hg-SE1088-Ab-2Anti-Human LYZL6 monoclonal antibodyHuman
GM-Tg-rg-SE1088-Ab-1/ GM-Tg-rg-SE1088-Ab-2Anti-Rat LYZL6 monoclonal antibodyRat
GM-Tg-mg-SE1088-Ab-1/ GM-Tg-mg-SE1088-Ab-2Anti-Mouse LYZL6 monoclonal antibodyMouse
GM-Tg-cynog-SE1088-Ab-1/ GM-Tg-cynog-SE1088-Ab-2Anti-Cynomolgus/ Rhesus macaque LYZL6 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1088-Ab-1/ GM-Tg-felg-SE1088-Ab-2Anti-Feline LYZL6 monoclonal antibodyFeline
GM-Tg-cang-SE1088-Ab-1/ GM-Tg-cang-SE1088-Ab-2Anti-Canine LYZL6 monoclonal antibodyCanine
GM-Tg-bovg-SE1088-Ab-1/ GM-Tg-bovg-SE1088-Ab-2Anti-Bovine LYZL6 monoclonal antibodyBovine
GM-Tg-equg-SE1088-Ab-1/ GM-Tg-equg-SE1088-Ab-2Anti-Equine LYZL6 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1088-Ab-1/ GM-Tg-hg-SE1088-Ab-2; GM-Tg-rg-SE1088-Ab-1/ GM-Tg-rg-SE1088-Ab-2;
GM-Tg-mg-SE1088-Ab-1/ GM-Tg-mg-SE1088-Ab-2; GM-Tg-cynog-SE1088-Ab-1/ GM-Tg-cynog-SE1088-Ab-2;
GM-Tg-felg-SE1088-Ab-1/ GM-Tg-felg-SE1088-Ab-2; GM-Tg-cang-SE1088-Ab-1/ GM-Tg-cang-SE1088-Ab-2;
GM-Tg-bovg-SE1088-Ab-1/ GM-Tg-bovg-SE1088-Ab-2; GM-Tg-equg-SE1088-Ab-1/ GM-Tg-equg-SE1088-Ab-2
Products NameAnti-LYZL6 monoclonal antibody
Formatmab
Target NameLYZL6
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-LYZL6 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1088-Ag-1Recombinant multi-species LYZL6/ HEL-S-6a/ LYC1 protein


    Target information

    Target IDGM-SE1088
    Target NameLYZL6
    Gene ID57151,69444,287751,716662,123381870,540048,100063794
    Gene Symbol and Synonyms1700023H08Rik,HEL-S-6a,LYC1,LYZB,LYZL6,PRO1485,RGD1306968,TKAL754,UNQ754
    Uniprot AccessionO75951,Q29RT1
    Uniprot Entry NameLYZL6_HUMAN,LYZL6_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000275722
    Target ClassificationN/A

    The target: LYZL6, gene name: LYZL6, also named as HEL-S-6a, LYC1, LYZB, PRO1485, TKAL754, UNQ754. This gene encodes a member of the C-type lysozyme/alpha-lactalbumin family. C-type lysozymes are bacteriolytic factors that play a role in host defense, whereas alpha-lactalbumins mediate lactose biosynthesis. The encoded protein contains catalytic residues characteristic of C-type lysozymes and may play a role in male reproduction. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, Jan 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.